Your story awaits

Cantos Ventures
Cantos Ventures
49
companies
388
Jobs
resistanceBio
resistanceBio

resistanceBio has built the first cancer treatment resistance system to predict how multiple cancer types will respond to approved or novel treatments. The ResCu platform aims only to advance therapies that have the potential to be superior to the standard of care and significantly extend patients’ lives. ResCu addresses the root cause of treatment failure, which is treatment resistance.
San Carlos, CA, USA, San Francisco, CA, USA
resistance.bio
Inaccurate data? Flag it here.
Open jobs at resistanceBio